Une tumeur endocrine bien différenciée = Clinical case : A well-differentiated endocrine tumorDUCREUX, Michel; BAUDIN, Eric.Gastroentérologie clinique et biologique. 2006, Vol 30, Num 2, pp 292-294, issn 0399-8320, 3 p.Article

Stratégie d'explorations radiologiques pour le bilan d'extension et la surveillance des tumeurs endocrines : Imagerie et cancer = Imaging strategy for staging and follow-up of endocrine tumorsDROMAIN, Clarisse; BAUDIN, Eric.Bulletin du cancer. 2006, Vol 93, Num 12, pp 1183-1189, issn 0007-4551, 7 p.Article

Biologie et imagerie des tumeurs neuro-endocrines : Tumeurs neuro-endocrines = Imaging and biology in neuroendocrine tumours : Neuroendocrine tumoursBAUDIN, Eric; DROMAIN, Clarisse.La Revue du praticien (Paris). 2002, Vol 52, Num 3, pp 268-273, issn 0035-2640Article

Méthodologie et utilisation du dosage de la chromogranine A en biologie clinique = methodological aspects and clinical value of chromogranin A assessmentBAUDIN, Eric; DEGORCE, Francois.MS. Médecine sciences. 2001, Vol 17, Num 4, pp 438-447, issn 0767-0974Article

Cancers réfractaires de la thyroïde : Maladie thyroïdienne = Refractory thyroid cancersSCHLUMBERGER, Martin; CHOUGNET, Cécile; BAUDIN, Eric et al.La Presse médicale (1983). 2011, Vol 40, Num 12, pp 1189-1198, issn 0755-4982, 10 p., CAH1Article

Angiogenèse et cancer de la thyroïde = Angiogenesis and thyroid cancerFRANCIS, Zelia; BAUDIN, Eric; LEBOULLEUX, Sophie et al.La Presse médicale (1983). 2009, Vol 38, Num 11, pp 1641-1646, issn 0755-4982, 6 p.Article

Progrès récents dans la prise en charge des tumeurs endocrinesBAUDIN, Eric; BACHELOT, Anne; DUCREUX, Michel et al.MTE. Médecine thérapeutique endocrinologie. 2001, Vol 3, Num SEP, pp 18-24, issn 1295-9359, NSArticle

Démarche diagnostique devant un nodule thyroïdienBACHELOT, Anne; LECLERE, Jérome; BAUDIN, Eric et al.MTE. Médecine thérapeutique endocrinologie. 2002, Vol 4, Num 1, pp 48-52, issn 1295-9359Article

Stratégie de traitement des tumeurs neuro-endocrines : Tumeurs neuro-endocrines = Therapeutic strategy of neuroendocrine tumours : Neuroendocrine tumoursDUCREUX, Michel; BAUDIN, Eric; SCHLUMBERGER, Martin et al.La Revue du praticien (Paris). 2002, Vol 52, Num 3, pp 290-296, issn 0035-2640Article

Traitement médical des métastases hépatiques de tumeurs neuro-endocrines digestives et pancréatiques : Les tumeurs neuro-endocrines (2e partie) = Non surgical treatment of pancreatic and digestive neuroendocrine tumors hepatic metastasisDUCREUX, Michel; BAUDIN, Eric; BOIGE, Valérie et al.Hépato-gastro (Montrouge). 2000, Vol 7, Num 6, pp 443-450, issn 1253-7020Article

Medullary thyroid carcinomaLEBOULLEUX, Sophie; BAUDIN, Eric; TRAVAGLI, Jean-Paul et al.Clinical endocrinology (Oxford. Print). 2004, Vol 61, Num 3, pp 299-310, issn 0300-0664, 12 p.Article

Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance : preliminary resultsFAGGIANO, Antongiulio; LEBOULLEUX, Sophie; YOUNG, Jacques et al.Clinical endocrinology (Oxford. Print). 2006, Vol 64, Num 1, pp 110-113, issn 0300-0664, 4 p.Article

TSH recombinante humaine en thérapieDOCAO, Christine; BACHELOT, Anne; GUILABERT, Nadine et al.MTE. Médecine thérapeutique endocrinologie. 2001, Vol 3, Num 5, pp 378-381, issn 1295-9359Article

Vandétanib, modalités pratiques d'utilisation dans le traitement des patients atteints de cancer médullaire de la thyroïde = Vandetanib, in the management of patients with locally advanced or metastatic medullary thyroid carcinomasCHOUGNET, Cecile N; SCHLUMBERGER, Martin; LEBOULLEUX, Sophie et al.Bulletin du cancer. 2014, Vol 101, Num 9, pp 891-895, issn 0007-4551, 5 p.Article

Prise en charge des tumeurs neuroendocrines métastatiques = Management of metastatic neuroendocrine tumorsBAUDIN, Eric; GUIGAY, Joel; DUCREUX, Michel et al.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S85-S86, HS1Conference Paper

Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical CancerBERRUTI, Alfredo; FASSNACHT, Martin; LEBOULLEUX, Sophie et al.European urology. 2014, Vol 65, Num 4, pp 832-838, issn 0302-2838, 7 p.Article

Malignant insulinoma: Recommendations for characterisation and treatmentBAUDIN, Eric; CARON, Philippe; SCOAZEC, Jean-Yves et al.Annales d'endocrinologie. 2013, Vol 74, Num 5-6, pp 523-533, issn 0003-4266, 11 p.Article

Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid CancerBRASSARD, Maryse; NERAUD, Barbara; YOUNG, Jacques et al.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 9, pp 2741-2749, issn 0021-972X, 9 p.Article

Prognostic parameters of metastatic adrenocortical carcinomaASSIE, Guillaume; ANTONI, Guillemette; BERTHERAT, Jérome et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 1, pp 148-154, issn 0021-972X, 7 p.Article

Mitotane has an estrogenic effect on sex hormone- binding globulin and corticosteroid-binding globulin in humansNADER, Nancy; RAVEROT, Gérald; EMPTOZ-BONNETON, Agnès et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 6, pp 2165-2170, issn 0021-972X, 6 p.Article

Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgeryHARTL, Dana M; TRAVAGLI, Jean-Paul; LEBOULLEUX, Sophie et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 5, pp 3084-3088, issn 0021-972X, 5 p.Article

Liver resection (and associated extra-hepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective studyELIAS, Dominique; LASSER, Philippe; BAUDIN, Eric et al.Surgery. 2003, Vol 133, Num 4, pp 375-382, issn 0039-6060, 8 p.Article

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) - A phase II non-randomised trialMITRY, Emmanuel; WALTER, Thomas; ROUGIER, Philippe et al.European journal of cancer (1990). 2014, Vol 50, Num 18, pp 3107-3115, issn 0959-8049, 9 p.Article

Combination Chemotherapy in Advanced Adrenocortical CarcinomaFASSNACHT, Martin; TERZOLO, Massimo; SORBYE, Halfdan et al.The New England journal of medicine. 2012, Vol 366, Num 23, pp 2189-2197, issn 0028-4793, 9 p.Article

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III TrialWELLS, Samuel A; ROBINSON, Bruce G; READ, Jessica et al.Journal of clinical oncology. 2012, Vol 30, Num 2, pp 134-141, issn 0732-183X, 8 p.Article